Business Wire

Grimaldi’s Pizzeria Announces International Development Agreement for Expansion into United Arab Emirates

29.3.2017 12:00 | Business Wire

Del

Grimaldi’s Pizzeria announced today, the company plans to expand internationally by opening five of its world-famous, coal-fired, brick-oven pizzerias in the United Arab Emirates over the next five years. Partnering with Tablez Food Company to ensure a seamless expansion, this international franchise agreement represents Grimaldi's first brand expansion beyond North America.

Tablez Food Company, an entity specializing in the development of unique food and beverage concepts, was the premiere partner of choice for Grimaldi’s due to its vast experience in international expansion efforts in the region with other notable franchise ventures. Grimaldi’s Pizzeria, one of the most awarded pizzerias in the United States and the only upscale pizzeria to be bestowed the coveted Five Star Diamond Award, represents the first and only pizza concept in Tablez's renowned portfolio.

“Since its inception, Grimaldi's has been singularly focused on serving exemplary food to its guests. That is why we recognized this international franchise opportunity as being an ideal partnership,” explained Grimaldi's Pizzeria CEO Joseph Ciolli. “Not only will we be able to treat new UAE customers to a truly uncompromised, coal-fired New York pizza experience, but also benefit from the reassurance that comes from working with Tablez, far and away the UAE's finest food and beverage group.”

“Our vision of becoming the UAE's leading player in the food & beverage retail sector is clearly furthered by this partnership,” said Tablez Food Company CEO Shafeena Yusuff Ali. “By bringing a world-class brand like Grimaldi's Pizzeria to the region, our customers will enjoy a truly unique offering of great tasting coal-fired pizza, made with the freshest, high-quality ingredients. Grimaldi's brings a long-standing reputation for excellence – and it is that consistency of product and passion that makes it the ideal brand to introduce to UAE.”

Beyond the Middle East, Grimaldi’s Pizzeria has engaged other investment groups in key growth markets around the globe in an effort to secure multi-unit franchise partners to introduce and develop the brand in regions including Southeast Asia, South America, Central America, Europe, Mexico, Canada and Australia.

For more information on Grimaldi’s Pizzeria’s international expansion efforts, visit: https://www.grimaldispizzeria.com/international_growth.aspx

To learn more about international franchise opportunities with Grimaldi’s Pizzeria, visit: https://www.grimaldispizzeria.com/international_qualifications_process.aspx.

To inquire about becoming an international franchisee, click here: https://www.grimaldispizzeria.com/franchise_apply.aspx

About Grimaldi’s Pizzeria

Founded in Brooklyn, New York, Grimaldi’s Pizzeria has been consistently chosen as America's undisputed favorite coal-fired pizza offering. From its 1200-degree coal-fired ovens that deliver impeccable pies and calzones, topped or filled with the freshest ingredients, Grimaldi's has seen its enthusiastic customers support drive expansion to 50 company-owned restaurants across the United States. The brand's signature coal-burning ovens produce a unique flavor and crust crispness that is just not possible from gas, convection, or wood burning methods. Grimaldi's contends that their ongoing brand success correlates directly with three simple principles – People, Product and Service. For more information, please visit www.grimaldispizzeria.com.

About Tablez

Tablez Food Company is the F&B arm of the prestigious Lulu International Group LLC; a highly diversified group headlined by the retail division with presence in Imports & Exports, Trading, Shipping, IT, Travel & Tourism, Hotels, Mall Development, Hyper Markets and Education in addition to F&B in the present day.

Established in 2010, Tablez Food Company specializes in unique home grown, international and local cuisines as well as partnering with leading franchising concepts with renowned success and exceptional food quality. The company dedicates itself to creativity and innovation by bringing new concepts that offer truly inspiring dining experiences to their guests. Currently, Tablez operates 35 outlets in the region with concepts including Peppermill, Bloomsbury’s, London Dairy, Famous Dave’s BBQ, Cold Stone Creamery®, Sugar Factory, Galito’s and Genghis Grill. Tablez will continue to see a series of new food concept launches over the next two years. For more information, visit http://www.tablez.com/.

Contact information

Preferred Public Relations
Emma Williams, 702-254-5704
emma@preferredpublicrelations.com
or
Grimaldi's Pizzeria
Investor Relations
David Fieramosca, 702-927-9485
Dfieramosca@grimaldispizzeria.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 07:08Pressemelding

Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven

Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 06:00Pressemelding

Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom